Bank of New York Mellon Corp - ALDEYRA THERAPEUTICS INC ownership

ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 98 filers reported holding ALDEYRA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 2.35 and the average weighting 0.1%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of ALDEYRA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,184,785
-20.5%
177,363
-0.1%
0.00%
Q2 2023$1,490,039
+126.3%
177,597
+167.9%
0.00%
Q1 2023$658,389
+43.2%
66,303
+0.4%
0.00%
Q4 2022$459,638
+29.8%
66,040
-0.3%
0.00%
Q3 2022$354,000
+12.7%
66,222
-15.6%
0.00%
Q2 2022$314,000
-66.3%
78,475
-62.6%
0.00%
Q1 2022$932,000
+24.4%
209,815
+12.2%
0.00%
Q4 2021$749,000
-53.6%
187,067
+1.8%
0.00%
Q3 2021$1,614,000
-35.9%
183,809
-17.2%
0.00%
Q2 2021$2,516,000
+346.9%
222,001
+368.8%
0.00%
Q1 2021$563,000
+45.1%
47,354
-16.4%
0.00%
Q4 2020$388,000
+237.4%
56,674
+264.5%
0.00%
Q3 2020$115,000
+76.9%
15,5480.0%0.00%
Q2 2020$65,000
-60.6%
15,548
-76.7%
0.00%
Q1 2020$165,000
-61.7%
66,794
-10.1%
0.00%
Q4 2019$431,000
+5.4%
74,257
-4.2%
0.00%
Q3 2019$409,000
-9.5%
77,547
+2.9%
0.00%
Q2 2019$452,000
-28.4%
75,353
+7.7%
0.00%
Q1 2019$631,000
-45.4%
69,947
-49.8%
0.00%
Q4 2018$1,156,000
-35.6%
139,305
+7.1%
0.00%
Q3 2018$1,795,000
+353.3%
130,015
+160.9%
0.00%
Q2 2018$396,000
+153.8%
49,842
+139.7%
0.00%
Q1 2018$156,000
+24.8%
20,791
+13.1%
0.00%
Q4 2017$125,000
-6.7%
18,378
-1.0%
0.00%
Q3 2017$134,00018,5700.00%
Other shareholders
ALDEYRA THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Prosight Management, LP 908,488$6,232,0002.88%
Knoll Capital Management, LLC 569,405$3,906,0002.66%
Mesirow Financial Investment Management, Inc. 64,698$443,828,0001.40%
Ghost Tree Capital, LLC 650,000$4,459,0000.99%
Johnson & Johnson Innovation - JJDC, Inc. 594,834$4,081,0000.53%
Perceptive Advisors 6,285,458$43,118,0000.46%
Affinity Asset Advisors, LLC 100,000$686,0000.36%
ACUTA CAPITAL PARTNERS, LLC 192,500$1,321,0000.36%
Avidity Partners Management LP 1,435,000$9,844,0000.32%
APOGEM CAPITAL LLC 55,821$383,0000.26%
View complete list of ALDEYRA THERAPEUTICS INC shareholders